HomeBUSINESS
BUSINESS

Daiichi Sankyo, Osaka Univ. Spin-Off to Jointly Develop iPS Cell-Derived Cardiomyocyte Sheet, Aiming at Commercialization within 5 Years
(Oct.6.2017)

Daiichi Sankyo Chairman Nakayama (far right) and Prof. Sawa (second from right)
Daiichi Sankyo and the Osaka University spin-off Cuorips Inc. aim to initiate clinical research of an iPS cell-derived cardiomyocyte sheet as early as next year. The two companies outlined their plans at a press conference held in Tokyo on October 5 ...
(LOG IN FOR FULL STORY)

News Calendar